Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAmortization - GoodwillCost of RevenueEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Issued
Ratios

Integra Lifesciences Holdings (IART) Leases (2019 - 2025)

Integra Lifesciences Holdings (IART) has disclosed Leases for 11 consecutive years, with $140.6 million as the latest value for Q4 2025.

  • Quarterly Leases fell 2.41% to $140.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $140.6 million through Dec 2025, down 2.41% year-over-year, with the annual reading at $140.6 million for FY2025, 2.41% down from the prior year.
  • Leases hit $140.6 million in Q4 2025 for Integra Lifesciences Holdings, up from $138.2 million in the prior quarter.
  • In the past five years, Leases ranged from a high of $156.8 million in Q3 2023 to a low of $81.6 million in Q1 2022.
  • Historically, Leases has averaged $131.4 million across 5 years, with a median of $144.6 million in 2022.
  • Biggest five-year swings in Leases: fell 10.45% in 2022 and later surged 79.45% in 2023.
  • Year by year, Leases stood at $84.5 million in 2021, then surged by 75.39% to $148.3 million in 2022, then grew by 5.33% to $156.2 million in 2023, then fell by 7.77% to $144.0 million in 2024, then dropped by 2.41% to $140.6 million in 2025.
  • Business Quant data shows Leases for IART at $140.6 million in Q4 2025, $138.2 million in Q3 2025, and $136.6 million in Q2 2025.